Internal Medicine, Cardiovascular Disease · Tampa, FL
NPI
1316934532
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5 Tampa General Cir
Tampa, FL, 33606
Phone (813) 251-0793
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
1,131 services
Medicare patients, 2024
259
Average age 72
Drug cost, 2024
$3.3M
4,138 prescriptions
Company payments, 2025
$1,242
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter J Berman was code G0422 (intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session), 456 times for 31 patients. In total Peter J Berman billed 1,131 services in 30 codes, and Medicare paid $84K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 456 | 31 | $99.11 | $45K |
| 99214 Office E&M - Established | Facility | 313 | 155 | $69.35 | $22K |
| 93010 Electrocardiogram | Facility | 80 | 78 | $6.03 | $483 |
| 93306 Echocardiography (TTE/TEE) | Facility | 76 | 70 | $50.26 | $3,820 |
| 99215 Office E&M - Established | Facility | 40 | 39 | $101.94 | $4,077 |
| 99205 Office E&M - New | Facility | 30 | 30 | $142.26 | $4,268 |
| 93018 Electrocardiogram | Facility | 22 | 22 | $10.62 | $234 |
By year: 2022 $71K for 1,131 services; 2023 $51K for 748 services; 2024 $84K for 1,131 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter J Berman prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 260 prescriptions and refills. In total Peter J Berman wrote 4,138 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 260 | 672 | 70 | $421K |
| Atorvastatin Calcium Generic | 217 | 597 | 71 | $2,368 |
| Farxiga Dapagliflozin Propanediol | 216 | 509 | 55 | $278K |
| Metoprolol Succinate Generic | 212 | 610 | 74 | $3,804 |
| Eliquis Apixaban | 146 | 304 | 40 | $169K |
| Amlodipine Besylate Generic | 135 | 392 | 47 | $1,079 |
| Carvedilol Generic | 133 | 355 | 45 | $1,123 |
| Spironolactone Generic | 124 | 355 | 42 | $1,211 |
| Jardiance Empagliflozin | 107 | 290 | 33 | $159K |
| Pantoprazole Sodium Generic | 106 | 230 | 30 | $1,014 |
| Losartan Potassium Generic | 106 | 311 | 29 | $1,083 |
| Rosuvastatin Calcium Generic | 104 | 290 | 32 | $1,535 |
| Furosemide Generic | 102 | 290 | 44 | $656 |
| Eplerenone Generic | 100 | 285 | 33 | $11K |
| Bumetanide Generic | 91 | 237 | 36 | $3,057 |
Brand drugs: - claims; generic drugs: 2,966 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter J Berman $1,242 ($1,242 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $237.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $237 |
| Abiomed JNJ | 2 | $236 |
| Kestra Medical Technology Services, Inc. | 1 | $175 |
| CVRx, Inc. CVRX | 1 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $148 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $114 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $51.92 |
| Abbott Laboratories ABT | 2 | $38.63 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $30.18 |
| BioVentrix, Inc. | 1 | $23.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.